Molecular Sequence Variation
8
4
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Molecular Diagnosis of Systemic Autoinflammatory Diseases
Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors
CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
COVID-19 Genomic Sequencing for Nosocomial Outbreak Investigations
Other Oncogene Mutations for Anti-EGFR Efficacy in Patients With Left-sided RAS-wild Type Metastatic Colorectal Cancer
Histomolecular Profiles of Gliomas in Children and Adolescent/Young Adults
Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas
Regenerative Surgical Treatment of Peri-implantitis